These findings suggest that targeting the CREB1‐CENPE axis and its downstream signalling could offer a promising therapeutic strategy for ccRCC, opening new avenues for potential treatment options in this malignancy. Here, CENPE is linked to nonpapillary renal cell carcinoma.